Theravance Biopharma Stock Math Transform Tanh Of Price Series
| TBPH Stock | USD 19.53 0.13 0.67% |
| Symbol |
Transformation |
The output start index for this execution was zero with a total number of output elements of sixty-one. Theravance Biopharma Tanh Of Price Series is a hyperbolic price transformation function.
Theravance Biopharma Technical Analysis Modules
Most technical analysis of Theravance Biopharma help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Theravance from various momentum indicators to cycle indicators. When you analyze Theravance charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Theravance Biopharma Predictive Technical Analysis
Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Theravance Biopharma. We use our internally-developed statistical techniques to arrive at the intrinsic value of Theravance Biopharma based on widely used predictive technical indicators. In general, we focus on analyzing Theravance Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Theravance Biopharma's daily price indicators and compare them against related drivers, such as math transform and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of Theravance Biopharma's intrinsic value. In addition to deriving basic predictive indicators for Theravance Biopharma, we also check how macroeconomic factors affect Theravance Biopharma price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
| 2025 | 2026 (projected) | Payables Turnover | 23.99 | 12.6 | Days Of Inventory On Hand | 916.86 | 603.75 |
Be your own money manager
As an individual investor, you need to find a reliable way to track all your investment portfolios' performance accurately. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing you full analytical transparency into your positions, our tools can tell you how much better you can do without increasing your risk or reducing expected return.Generate Optimal Portfolios
Align your risk and return expectations
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Theravance Biopharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment. For more detail on how to invest in Theravance Stock please use our How to Invest in Theravance Biopharma guide.You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Is there potential for Pharmaceuticals market expansion? Will Theravance introduce new products? Factors like these will boost the valuation of Theravance Biopharma. If investors know Theravance will grow in the future, the company's valuation will be higher. Understanding fair value requires weighing current performance against future potential. All the valuation information about Theravance Biopharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 0.57 | Revenue Per Share | Quarterly Revenue Growth 0.185 | Return On Assets | Return On Equity |
The market value of Theravance Biopharma is measured differently than its book value, which is the value of Theravance that is recorded on the company's balance sheet. Investors also form their own opinion of Theravance Biopharma's value that differs from its market value or its book value, called intrinsic value, which is Theravance Biopharma's true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because Theravance Biopharma's market value can be influenced by many factors that don't directly affect Theravance Biopharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Theravance Biopharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Theravance Biopharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Meanwhile, Theravance Biopharma's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.